Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 7Recruiting 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 17Glioblastoma 8Esophageal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Oropharyngeal Neoplasms 7Breast Neoplasms 7Mouth Neoplasms 6Glioma 6Triple Negative Breast Neoplasms 4Lung Neoplasms 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Stomach Neoplasms 3Sarcoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Neuroblastoma 2Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2Medulloblastoma 2Hypopharyngeal Neoplasms 2Ganglioneuroblastoma 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13Docetaxel 13sintilimab 12Drug Therapy 12Trastuzumab 11tislelizumab 10Cisplatin 10Irinotecan 9Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Hyperthermic Intraperitoneal Chemotherapy 7Biopsy 7fludarabine 6disitamab vedotin 6Cyclophosphamide 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × Radiation × Clear all
NCT03161522 2026-04-15

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT04221893 2025-10-06

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco

Phase NA Recruiting
28 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Anal Canal Carcinoma, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms

NCT05687357 2023-04-19

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Recruiting
140 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡